Limits...
Prevalence of modifiable cardiovascular risk factors in long-term renal transplant patients.

Vivek V, Bhandari S - Int J Nephrol Renovasc Dis (2010)

Bottom Line: Multivariable analysis was performed on those factors found to achieve a P value of less than 0.20 after univariate analysis to test for significance in relation to cardiovascular risk as the primary factor.Univariate analysis revealed diabetes and age, and subsequent multivariable analysis revealed age only, as being significantly associated with cardiovascular outcomes.Age is an important determinant of cardiovascular risk.

View Article: PubMed Central - PubMed

Affiliation: Department of Renal Medicine, Hull and East Yorkshire Hospitals NHS Trust and Hull York Medical School, East Yorkshire, UK.

No MeSH data available.


Related in: MedlinePlus

Mean fasting Homocystine levels in patents with (NODAT) and without (ND) new onset diabetes after transplantation.
© Copyright Policy
Related In: Results  -  Collection


getmorefigures.php?uid=PMC3108770&req=5

f3-ijnrd-3-175: Mean fasting Homocystine levels in patents with (NODAT) and without (ND) new onset diabetes after transplantation.

Mentions: Homocysteine levels were similarly elevated in both groups (17.5 μmol/L and 15.6 μmol/L, respectively, Figure 3), and 78% had a level greater than 12 μmol/L. There was a positive correlation of homocysteine with serum creatinine (r = 0.3), age (r = 0.32), and serum albumin (r = 0.4). This correlation was more pronounced in patients with NODAT. Previously it has been noted that transplant patients on cyclosporine tend to have higher homocysteine levels.14 However, we found no such trend in this select cohort of transplant patients.


Prevalence of modifiable cardiovascular risk factors in long-term renal transplant patients.

Vivek V, Bhandari S - Int J Nephrol Renovasc Dis (2010)

Mean fasting Homocystine levels in patents with (NODAT) and without (ND) new onset diabetes after transplantation.
© Copyright Policy
Related In: Results  -  Collection

Show All Figures
getmorefigures.php?uid=PMC3108770&req=5

f3-ijnrd-3-175: Mean fasting Homocystine levels in patents with (NODAT) and without (ND) new onset diabetes after transplantation.
Mentions: Homocysteine levels were similarly elevated in both groups (17.5 μmol/L and 15.6 μmol/L, respectively, Figure 3), and 78% had a level greater than 12 μmol/L. There was a positive correlation of homocysteine with serum creatinine (r = 0.3), age (r = 0.32), and serum albumin (r = 0.4). This correlation was more pronounced in patients with NODAT. Previously it has been noted that transplant patients on cyclosporine tend to have higher homocysteine levels.14 However, we found no such trend in this select cohort of transplant patients.

Bottom Line: Multivariable analysis was performed on those factors found to achieve a P value of less than 0.20 after univariate analysis to test for significance in relation to cardiovascular risk as the primary factor.Univariate analysis revealed diabetes and age, and subsequent multivariable analysis revealed age only, as being significantly associated with cardiovascular outcomes.Age is an important determinant of cardiovascular risk.

View Article: PubMed Central - PubMed

Affiliation: Department of Renal Medicine, Hull and East Yorkshire Hospitals NHS Trust and Hull York Medical School, East Yorkshire, UK.

No MeSH data available.


Related in: MedlinePlus